Forte Biosciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Forte Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2024.
  • Forte Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $697K, a 10.6% decline year-over-year.
  • Forte Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $3.1M, a 5.76% decline year-over-year.
  • Forte Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $3.1M, a 5.76% decline from 2023.
  • Forte Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.28M, a 18.2% decline from 2022.
  • Forte Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.02M, a 4.72% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.1M -$189K -5.76% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 $3.28M -$731K -18.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 $4.02M -$199K -4.72% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $4.21M +$3.26M +341% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $956K +$920K +2556% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $36K -$6.83M -99.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $6.87M +$2.42M +54.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $4.45M +$3.13M +236% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $1.32M +$261K +24.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $1.06M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.